Fesariustherapeutics, Inc. · Class U · Cleared Jan 6, 2025
| K-number | K241904 |
| Device name | DermiSphere Dermal Template |
| Applicant | Fesariustherapeutics, Inc. |
| Product code | KGN |
| Device class | Class U |
| Decision date | Jan 6, 2025 |
| Decision | Substantially Equivalent |
| Regulation | — |
DermiSphere™ hDRT is a wound dressing made from crosslinked bovine collagen microspheres embedded in a bovine collagen hydrogel matrix. It is indicated for managing various wounds including partial and full-thickness wounds, pressure ulcers, venous and diabetic ulcers, surgical wounds, trauma wounds, and draining wounds as a single-use device.
The subject device uses Type I bovine collagen from dermis with crosslinked microspheres as a subcomponent, whereas the predicate (Avagen) uses collagen from bovine tendon with glycosaminoglycan (GAG) and is fully crosslinked. Both provide scaffolding for cellular invasion and capillary growth; the subject device has slightly lower drapability (7.88 mm vs 8.97 mm). The subject device is available in smaller sizes (4×5 cm and 10×12 cm) compared to the predicate's larger sizes.
Testing was performed in accordance with ISO 10993-1 for biocompatibility testing matrix and ISO 10993-18 for exhaustive extraction chemical characterization. Bench testing included dimensions, drapability, and pyrogenicity assessment.
Both devices are collagen-based biodegradable wound dressings with identical indications for use and the same mode of action (providing a scaffold for tissue invasion and vascularization). Although the subject device uses dermis-sourced collagen with crosslinked microspheres while the predicate uses tendon collagen with GAG, the material differences are not significant because both primarily comprise Type I bovine collagen and achieve equivalent collagen stability and biological function. Biocompatibility testing and bench characterization demonstrate the subject device raises no different safety or effectiveness questions.
View the full FDA submission: accessdata.fda.gov